High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is designed to test the hypothesis that high dose candesartan treatment compared to quinapril is able to reduce intima hyperproliferation and the restenosis rate after stent angioplasty in peripheral occlusive artery disease.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Technische Universität Dresden
• Treatments: Candesartan; Candesartan cilexetil; Quinapril

Criteria

Inclusion Criteria:

• male and female

• peripheral occlusive arterial disease Stad IIb Fontaine classification

Exclusion Criteria:

• patients with lesions not available for PTA

• renal insufficiency

• patients on calcium-antagonists